Hypoxia-inducible factor-1α expression and gemcitabine chemotherapy for pancreatic cancer

Oncology Reports

Volumn 26, Issue 6, 2011, Pages 1399-1406

  Kasuya, Kazuhiko ^a   Tsuchida, Akihiko ^a   Nagakawa, Yuichi ^a   Suzuki, Minako ^a   Abe, Yuta ^b   Itoi, Takao ^a   Serizawa, Hiromi ^b   Nagao, Toshitaka ^a   Shimazu, Motohide ^b   Aoki, Tatsuya ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL UNIVERSITY HACHIOJI MEDICAL CENTER   (Japan)

Author keywords

Gemcitabine; HIF 1 ; Pancreatic cancer; SNP

Indexed keywords

GEMCITABINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DRUG EFFECT; DRUG SAFETY; FATIGUE; GENE MUTATION; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOPENIA; MICROVASCULARIZATION; OVERALL SURVIVAL; PANCREAS CARCINOMA; PANCREAS RESECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; TUMOR VASCULARIZATION;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CELL LINE, TUMOR; CELL SURVIVAL; DEOXYCYTIDINE; GENE EXPRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; PANCREATIC NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 80053532392     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1457     Document Type: Article

References (15)

1. Tanimoto K, Makino Y, Pereira T and Poellinger L: Mechanism of regulation of the hypoxia-inducible factor-1α by the von Hipple-Lindau tumor suppressor protein. EMBO J 19: 4298-4309, 2000. (Pubitemid 30623741)
2. Tanimoto K, Yoshiga K, Eguchi H, et al: Hypoxia-inducible factor-1α polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis 24: 1779-1783, 2003. (Pubitemid 37408141)
3. Chang Q, Qin R, Huang T, Gao J and Feng Y: Effect of antisense hypoxia-inducible factor 1α on progression, metastasis, and chemosensitivity of pancreatic cancer. Pancreas 32: 297-305, 2006.
4. Fechner G, Dederichs F, Schmidt D, Müller S, Vaupel P and Albers P: Hyperoxia-induced improvement of the in vitro response to gemcitabine in transitional cell carcinoma. Anticancer Res 25: 3413-3418, 2005. (Pubitemid 41109984)
5. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD and Semenza GL: Activation vascular endothelial growth factor gene transcription by hypoxia-inducible factor-1. Mol Cell Biol 16: 4604-4613, 1996. (Pubitemid 26272112)
6. Liu Y, Cox SR, Morita T and Kourembanas S: Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Circ Res 77: 638-643, 1995.
7. Yamada N, Horikawa Y, Oda N, Iizuka K, Shihara N, Kishi S and Takeda J: Genetic variation in the hypoxia-inducible factor-1α gene is associated with type2 diabetes in Japanese. J Clin Endocrinol Metab 90: 5841-5847, 2005. (Pubitemid 41415501)
8. Ling TS, Shi RH, Zhang GX, Zhu H, Yu LZ and Ding XF: Common single nucleotide polymorphism of hypoxia-inducible factor-1α and its impact on the clinicopathological features of esophageal squamous cell carcinoma. Chin J Dig Dis 6: 155-158, 2005.
9. Kuwai T, Kitadai Y, Tanaka S, et al: Single nucleotide polymorphism in the hypoxia-inducible factor-1α gene in colorectal carcinoma. Oncol Rep 12: 1033-1037, 2004.
10. Chau CH, Permenter MG, Steinberg SM, Retter AS, Dahut WL, Price DK and Figg WD: Polymorphism in the hypoxia-inducible factor-1alpha gene may confer susceptibility to androgen-independent prostate cancer. Cancer Biol Ther 4: 1222-1225, 2005.
11. Ollerenshaw M, Page T, Hammonds J and Demaine A: Polymorphisms in the hypoxia-inducible factor-1α gene (HIF1A) are associated with the renal cell carcinoma phenotype. Cancer Genet Cytogenet 153: 122-126, 2004. (Pubitemid 39592144)
12. Funato T and Takeda M: Expression of the hypoxia-inducible factor-1alpha gene in the anticancer drug resistance. Physico-Chem Biol 49 (Suppl): 30, 2005 (In Japanese).
13. Song X, Liu X, Chi W, Liu Y, Wei L, Wang X and Yu J: Hypoxia-induced resistance to cisplatin and doxorubicinin non-small cell lung cancer is inhibited by silencing of HIF-1 alpha gene. Cancer Chemother Phamacol 58: 776-784, 2006. (Pubitemid 44351258)
14. Wu XA, Sun Y, Fan OX, Wang LX, Wang RL and Zhang L: Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensisivity in esophageal squamous cell carcinoma cells under hypoxia. Zhonghua Yi Xue Za Zhi 37: 2640-2644, 2007 (In Chinese). (Pubitemid 351166176)
15. Urano N, Fujiwara Y, Diki Y, et al: Overexpression of hypoxia-inducible factor 1alpha in gastric adenocarcinoma. Gastric Cancer 9: 44-99, 2006.